Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalling Bosse

Showing results (31-40 of 167) with videos related to

Pageof 17
Sort By:
Gynecologic Oncology|October 4, 2015
Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinomaLinda S Nooij, Paulien J Ongkiehong, Erik W van Zwet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Reply to Comment on HPV-independent, p53-Wild-type Vulvar Intraepithelial Neoplasia: A Review of Nomenclature and the Journey to Characterize Acanthotic Precursor Lesions of the VulvaCarlos Parra-Herran, Marisa R Nucci, Naveena Singh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2022
HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulvaCarlos Parra-Herran, Marisa R Nucci, Naveena Singh, et al.
Gynecologic Oncology|February 21, 2025
Predicting lymph node metastases in three different vulvar squamous cell carcinoma subgroupsAnne F van Velzen, Adam J Tulling, Mariëtte I E van Poelgeest, et al.
Frontiers in Oncology|February 15, 2019
MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous CarcinomaNeha M Sahasrabudhe, Joost C van der Horst, Vivian Spaans, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 10, 2015
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-upNicoletta Colombo, Carien Creutzberg, Frederic Amant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 20, 2015
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-upNicoletta Colombo, Carien Creutzberg, Frederic Amant, et al.
Histopathology|April 3, 2020
Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinomaKim E Kortekaas, Nienke Solleveld-Westerink, Basile Tessier-Cloutier, et al.
BMJ Oncology|January 31, 2025
Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacyNeil Ryan, Mark Glaire, Thomas Walker, et al.
Gynecologic Oncology|February 22, 2014
High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinomaEllen Stelloo, Remi A Nout, Lisanne C L M Naves, et al.
Pageof 17

Showing results (31-40 of 167) with videos related to

Sort By:
Pageof 17
Gynecologic Oncology|October 4, 2015
Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinomaLinda S Nooij, Paulien J Ongkiehong, Erik W van Zwet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 28, 2023
Reply to Comment on HPV-independent, p53-Wild-type Vulvar Intraepithelial Neoplasia: A Review of Nomenclature and the Journey to Characterize Acanthotic Precursor Lesions of the VulvaCarlos Parra-Herran, Marisa R Nucci, Naveena Singh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2022
HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulvaCarlos Parra-Herran, Marisa R Nucci, Naveena Singh, et al.
Gynecologic Oncology|February 21, 2025
Predicting lymph node metastases in three different vulvar squamous cell carcinoma subgroupsAnne F van Velzen, Adam J Tulling, Mariëtte I E van Poelgeest, et al.
Frontiers in Oncology|February 15, 2019
MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous CarcinomaNeha M Sahasrabudhe, Joost C van der Horst, Vivian Spaans, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 10, 2015
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-upNicoletta Colombo, Carien Creutzberg, Frederic Amant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 20, 2015
ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-upNicoletta Colombo, Carien Creutzberg, Frederic Amant, et al.
Histopathology|April 3, 2020
Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinomaKim E Kortekaas, Nienke Solleveld-Westerink, Basile Tessier-Cloutier, et al.
BMJ Oncology|January 31, 2025
Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacyNeil Ryan, Mark Glaire, Thomas Walker, et al.
Gynecologic Oncology|February 22, 2014
High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinomaEllen Stelloo, Remi A Nout, Lisanne C L M Naves, et al.
Pageof 17